These 5 drug developers have jumped this week on hopes they can provide a coronavirus treatment

Advertisement

1. Novavax

1. Novavax

Ticker: NVAX

Thursday stock gains: As much as 27.9%

How it's trading now: Up 19.6%

Get more: The company announced Wednesday it began animal testing for a potential coronavirus vaccine. Human testing will begin by the end of spring 2020, the company said.

Advertisement

2. Inovio

2. Inovio

Ticker: INO

Thursday stock gains: As much as 25.3%

How it's trading now: Up 9.3%

Get more: Fox Business reported on February 13 that Inovio has a vaccine for the COVID-19 coronavirus, and will begin clinical trials this summer at the earliest.

Advertisement

4. Vaxart

4. Vaxart

Ticker: VXRT

Thursday stock gains: As much as 106.1%

How it's trading now: Up 53.3.7%

Get more: Vaxart said at the start of the month that it was starting a program to make a vaccine for COVID-19 coronavirus.

3. Moderna

3. Moderna

Ticker: MRNA

Thursday stock gains: As much as 23.5%

How it's trading now: Down 10.8%

Get more: Moderna announced Monday that it had shipped the first coronvirus vaccine for human testing.

Advertisement

5. Gilead

5. Gilead

Ticker: GILD

Thursday stock gains: As much as 5.6%

How it's trading now: Down 2.5%

Get more: The World Health Organization said that remdesivir could treat some symptoms of COVID-19 coronavirus. The company will conduct two clinical trials of the drug starting in March, it said in a Wednesday statement.